Trial Profile
A Phase III Study of MP-513 in Combination With Thiazolidinedione in Japanese Patients With Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary) ; Thiazolidinediones
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 26 Aug 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 26 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.